Paul Ross is a Consultant Medical Oncologist at Guy’s & St Thomas’ and King’s College Hospitals and Honorary Senior Lecturer at King’s College London. He specialises in the treatment of Gastro-intestinal malignancies focussing on colorectal cancer and hepatic, pancreatic and biliary (HPB) cancers. He is a member of the adjuvant and advanced disease sub-group of the Colorectal Cancer Clinical Studies group and is research lead for colorectal cancer for the South London Comprehensive Research Network. In addition, he is a member of the National Cancer Research Institute Upper GI Cancers Clinical Studies group and its hepato-biliary sub-group. In 2019 he became a member of NHS England’s Chemotherapy Clinical Reference group. His research interests are focussed around systemic therapies, personalised therapy, pharmacogenomics and clinical trials.
Paul is Chief Investigator of a number of trials including the CAPITAL trial for patient with metastatic colorectal cancer not suitable for doublet therapy. In the past he was a collaborator in the GOLD study. He is on the trial management group for a number of trials. Furthermore, he is a member of Independent Data monitoring committees for a number of studies.
Paul trained in Medical Oncology at the Royal Marsden Hospital and the Institute of Cancer Research where he was a Cancer Research Campaign Clinical Fellow. His Research was acknowledged by the award of the McElwain prize from the Association of Cancer Physicians and a Merit award from the American Society of Clinical Oncology. He is widely published in peer reviewed journals and has given presentations to both national and international meetings.